BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37392200)

  • 1. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
    Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer.
    Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F
    J Oncol; 2022; 2022():5034092. PubMed ID: 36276275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma.
    Chen S; Zhang S; Yuan Y; Wang Z; Li J; Li T; Zuo M; Feng W; Chen M; Liu Y
    Front Pharmacol; 2022; 13():1016520. PubMed ID: 36267281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
    Li J; Yin J; Li W; Wang H; Ni B
    Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
    Yang H; Yang J; Bian H; Wang X
    Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.
    Sha S; Si L; Wu X; Chen Y; Xiong H; Xu Y; Liu W; Mei H; Wang T; Li M
    Front Immunol; 2022; 13():922780. PubMed ID: 35979353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
    Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
    Front Genet; 2023; 14():1124439. PubMed ID: 36936439
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model.
    Cui J; Xiong Y; Liu Y; Sun M; Gu X; Zhong L; Hong X; Liu L
    Biomed Res Int; 2022; 2022():7406636. PubMed ID: 36588537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
    Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
    Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer.
    Zhang J; Jiang S; Gu D; Zhang W; Shen X; Qu M; Yang C; Wang Y; Gao X
    Front Oncol; 2023; 13():1162653. PubMed ID: 37205181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features.
    Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
    Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
    Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.